CXCL8 and leprosy: This result is consistent with those of our previous study in a population from Southwest China, where M. leprae antigen (ML2044)-induced IL-8 could distinguish PB leprosy patients from ECs in a leprosy-endemic area (Bobosha, et al., 2014; Chen et al., 2019).